IL83177A0 - Pharmaceutical compositions containing xylometazoline - Google Patents

Pharmaceutical compositions containing xylometazoline

Info

Publication number
IL83177A0
IL83177A0 IL83177A IL8317787A IL83177A0 IL 83177 A0 IL83177 A0 IL 83177A0 IL 83177 A IL83177 A IL 83177A IL 8317787 A IL8317787 A IL 8317787A IL 83177 A0 IL83177 A0 IL 83177A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
xylometazoline
containing xylometazoline
pharmaceutical
Prior art date
Application number
IL83177A
Original Assignee
Asche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asche Ag filed Critical Asche Ag
Publication of IL83177A0 publication Critical patent/IL83177A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
IL83177A 1986-07-18 1987-07-13 Pharmaceutical compositions containing xylometazoline IL83177A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863624624 DE3624624A1 (en) 1986-07-18 1986-07-18 PHARMACEUTICAL PREPARATIONS CONTAINING XYLOMETAZOLINE

Publications (1)

Publication Number Publication Date
IL83177A0 true IL83177A0 (en) 1987-12-31

Family

ID=6305642

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83177A IL83177A0 (en) 1986-07-18 1987-07-13 Pharmaceutical compositions containing xylometazoline

Country Status (12)

Country Link
EP (1) EP0282495B1 (en)
JP (1) JPH01500265A (en)
AU (1) AU7547387A (en)
DE (2) DE3624624A1 (en)
DK (1) DK149588A (en)
ES (1) ES2004454A6 (en)
FI (1) FI881271A (en)
GR (1) GR871134B (en)
IL (1) IL83177A0 (en)
PT (1) PT85350B (en)
WO (1) WO1988000473A1 (en)
ZA (1) ZA875281B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1011016C2 (en) * 1999-01-13 2000-07-14 Dagra Pharma Bv Nasal spray based on xylometazoline and chamomile extract.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3339236A1 (en) * 1983-10-28 1985-05-09 Bayer Ag PREPARATION OF MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
DK149588D0 (en) 1988-03-18
EP0282495B1 (en) 1991-06-19
PT85350B (en) 1989-10-16
DE3624624A1 (en) 1988-01-28
ES2004454A6 (en) 1989-01-01
ZA875281B (en) 1988-03-30
PT85350A (en) 1987-08-01
EP0282495A1 (en) 1988-09-21
GR871134B (en) 1987-11-20
FI881271A0 (en) 1988-03-17
DE3770939D1 (en) 1991-07-25
AU7547387A (en) 1988-02-10
JPH01500265A (en) 1989-02-02
WO1988000473A1 (en) 1988-01-28
FI881271A (en) 1988-03-17
DK149588A (en) 1988-03-18

Similar Documents

Publication Publication Date Title
GB2196964B (en) Pharmaceutical compositions
GB8716301D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8723121D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8608818D0 (en) Pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
PH25390A (en) Pharmaceutical compositions
GB8723120D0 (en) Pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GB8620073D0 (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GR871999B (en) Pharmaceutical compositions
IL83177A0 (en) Pharmaceutical compositions containing xylometazoline
GB8615041D0 (en) Pharmaceutical compositions
GB8616397D0 (en) Pharmaceutical compositions
ZA871721B (en) Pharmaceutical compositions
GB8612806D0 (en) Pharmaceutical compositions
GB8623587D0 (en) Pharmaceutical compositions
GB8611830D0 (en) Pharmaceutical compositions
GB8623588D0 (en) Pharmaceutical compositions